Riskpilot← Back to searchSign inGet full accessAtnahs Pharma Denmark ApS
APSActiveCVR 36699051Ørestads Boulevard 108, 5. tvWholesale of pharmaceutical and medical goods · NACE 4646Est. 2015— employees
Revenue 2025
DKK 71,4M
-22% vs 2024
EBITDA margin
1.9%
+47% vs 2024
Equity ratio
4.1%
Financial strength
Net profit 2025
DKK 48K
+134% vs 2024
| Revenue | DKK 71,4M | -22% |
| EBITDA | DKK 1,4M | +47% |
| Net profit | DKK 48K | +134% |
| Total assets | DKK 51,2M | -24% |
| Equity | DKK 2,1M | +3% |
| Employees | — | — |
Legal name
Atnahs Pharma Denmark ApS
CVR number
36699051
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
27. marts 2015
Share capital
DKK 50.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2025-03-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens medlemmer hver for sig eller af en direktør alene.
Company purpose
Selskabets formål er at drive handelsvirksomhed med farmaceutiske produkter, herunder udvikling, salg, distribution og markedsføring af farmaceutiske produkter og dermed beslægtet virksomhed.
Address
Ørestads Boulevard 108, 5. tv
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -396 | -477 | -1.428 | 779 | -1.259 | 5.093 | 9.762 | 517.226 | 91.292 | 71.428 |
| Staff expenses | -0 | -100 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -396 | 1.140 | -1.428 | 779 | -1.259 | 5.093 | 9.762 | -19.380 | 929 | 1.363 |
| Depreciation & amort. | -0 | -0 | -0 | -1.537 | -0 | -0 | -0 | -0 | 2 | -60 |
| EBIT | -396 | 1.140 | -1.428 | -758 | -1.259 | 5.093 | 9.762 | -19.380 | 927 | 1.303 |
| Net financials | -9 | 1.621 | -431 | -294 | -160 | -4.817 | -6.115 | 38.152 | -901 | -1.240 |
| Profit before tax | -405 | 1.044 | -1.858 | -1.052 | -1.418 | 275 | 3.647 | 18.771 | 27 | 63 |
| Tax | -95 | 236 | -0 | -0 | -0 | -0 | -0 | 4.051 | 6 | 15 |
| Net profit | -310 | 809 | -1.858 | -1.052 | -1.418 | 275 | 3.647 | 14.720 | 20 | 48 |
| Item | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 836 | 8.455 | 7.218 | 1.220 | 3.852 | 127.940 | 202.928 | 407.346 | 66.995 | 51.236 |
| Equity | -260 | 549 | -1.309 | -2.362 | -3.780 | -3.505 | 142 | 14.862 | 2.016 | 2.082 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.095 | 7.906 | 8.527 | 3.582 | 7.632 | 131.445 | 202.780 | 392.395 | 64.964 | 47.387 |
| Total debt | 1.095 | 7.906 | 8.527 | 3.582 | 7.632 | 131.445 | 202.780 | 392.395 | 64.964 | 47.387 |
EBITDA margin
1.9%
This company
15.8%
Market median
-88% vs market
20152025
Equity ratio
4.1%
This company
38.2%
Market median
-89% vs market
20152025
Return on equity
2.3%
This company
18.4%
Market median
-88% vs market
20152025
Net profit margin
0.1%
This company
8.1%
Market median
-99% vs market
20152025
Asset turnover
1.39×
This company
1.12×
Market median
+24% vs market
20152025
Debt / equity
23.61×
This company
0.62×
Market median
-3708% vs market
20152025
- Annual report 2025Filed via CVR / Virk · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via CVR / Virk · Period 2020-04-01 – 2021-03-31
- Annual report 2020Filed via CVR / Virk · Period 2019-04-01 – 2020-03-31
- Annual report 2019Filed via CVR / Virk · Period 2018-04-01 – 2019-03-31
- Annual report 2018Filed via CVR / Virk · Period 2017-04-01 – 2018-03-31
- Annual report 2017Filed via CVR / Virk · Period 2016-01-01 – 2017-03-31
- Annual report 2015Filed via CVR / Virk · Period 2015-03-27 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NB Management | Management | 2025 | — | — |
JS Management | Management | 2023 | — | — |
LJ Management | Management | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2016 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2026 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2019 | — | — | |
| Deputy Chairman | 2016 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2026 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2018 | |
| Individual | 33.3% | 33.3% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Atnahs Pharma Denmark ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Neeshe Bhikhubhai Williams | Management | 0 companies |
| James Sang Bum Lee | Management | 0 companies |
| Lisbet Johansen | Management | 0 companies |
| James Charles Burt | Board of Directors | 0 companies |
| Amit Vijaykumar Patel | Chairman | 0 companies |
| Alastair Thomas Badgett Hay | Board of Directors | 0 companies |
| Rishi Bhikhu | Board of Directors | 0 companies |
| Zubair Javeed | Board of Directors | 0 companies |
| Mohammad Muqtadir Samy | Chairman | 0 companies |
| Twan Johannes Anna Nouwen | Board of Directors | 0 companies |
| Mark John Cotterill | Board of Directors | 0 companies |
| Dipen Vijaykumar Patel | Deputy Chairman | 0 companies |
| Jesper Wilhelm Voss | Board of Directors | 0 companies |
| Felipe Andres Florez Arango | Board of Directors | 0 companies |
| Anthony Charles Playle | Board of Directors | 0 companies |
| Santsagar Patel | Board of Directors | 0 companies |
| Christoph Michael Habereder | Board of Directors | 0 companies |